Who invested in Keros Therapeutics?
Keros Therapeutics's investors include Venrock, OrbiMed, Foresite Capital, Arkin Bio and Global Health Sciences Fund, and 3 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$163Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 4 on the team.
On the board, as filediAlon LazarusCarl GordonJulius KnowlesNima FarzanRan NussbaumZafrira Avnur
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Keros Therapeutics's investors include Venrock, OrbiMed, Foresite Capital, Arkin Bio and Global Health Sciences Fund, and 3 more on record.
Keros Therapeutics has raised $163M across 2 rounds since 2019.
Keros Therapeutics's most recent round was an Undisclosed round of $140M in Jan 2024.
Its most recent round, $140M in Jan 2024, is also its largest on record.
Keros Therapeutics's first round on record, in Jan 2019, was backed by Arkin Bio, Global Health Sciences Fund and Medison Pharma and 2 others.
Keros Therapeutics's latest named round is an Undisclosed round, in Jan 2024.
Keros Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.